Medicare Enrolled

Dr. Remberto Bitar, M.D.

Pulmonary Disease · Kissimmee, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
1121 N CENTRAL AVE, Kissimmee, FL 34741
4079331221
In practice since 2006 (19 years)
NPI: 1386609899 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bitar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bitar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bitar

Dr. Remberto Bitar is a pulmonary disease in Kissimmee, FL, with 19 years in practice. Based on federal Medicare data, Dr. Bitar performed 36 Medicare services across 36 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bitar received a total of $129,650 from 32 pharmaceutical and/or device companies across 470 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bitar is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 36 Medicare services$ $129,650 industry payments

Medicare Practice Summary

Medicare Utilization ↗
36
Medicare services
Bottom 2% in FL for pulmonary disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
36
Unique beneficiaries
$174
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Critical care, first 30-74 min36$174$999
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2022 ↗
$129,650
Total received (2018-2022)
Avg $25,930/year across 5 years
Top 4% in FL for pulmonary disease
32
Companies
470
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$122,433 (94.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,328 (3.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,889 (2.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2022
$200
2021
$3,716
2020
$40,133
2019
$42,744
2018
$42,857

Payments by company (2022)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$64,977
Sunovion Pharmaceuticals Inc.
$43,530
Bayer HealthCare Pharmaceuticals Inc.
$7,616
AstraZeneca Pharmaceuticals LP
$4,746
ViiV Healthcare Company
$3,638
Mylan Specialty L.P.
$3,240
Genentech USA, Inc.
$316
Boehringer Ingelheim Pharmaceuticals, Inc.
$241
Actelion Pharmaceuticals US, Inc.
$231
Grifols USA, LLC
$125
Inspire Medical Systems, Inc.
$123
Novartis Pharmaceuticals Corporation
$118
PFIZER INC.
$110
Harmony Biosciences LLC
$69
Jazz Pharmaceuticals Inc.
$67
Insmed, Inc.
$57
Resmed Corp
$52
Merck Sharp & Dohme Corporation
$52
Mallinckrodt Enterprises LLC
$51
Circassia Pharmaceuticals Inc
$40
Mallinckrodt Hospital Products Inc.
$32
Regeneron Healthcare Solutions, Inc.
$31
Electromed, Inc.
$28
Relypsa, Inc.
$25
Abbott Laboratories
$24
Philips Electronics North America Corporation
$21
Melinta Therapeutics, LLC
$18
GENZYME CORPORATION
$18
Amarin Pharma Inc.
$17
ADVANCED RESPIRATORY, INC
$13
Mallinckrodt LLC
$12
Teva Pharmaceuticals USA, Inc.
$12
Top 3 companies account for 89.6% of total payments
Associated products mentioned in payments ›
ACTHAR · ANORO · ANORO ELLIPTA · Adempas · Arikayce · ArmonAir Digihaler · Astral · BEVESPI AEROSPHERE · BREO · BREZTRI AEROSPHERE · BROVANA · Baxdela · DUAKLIR PRESSAIR · DUPIXENT · Dreamstat Bipap Auto · Dymista · ELIQUIS · ENTRESTO · EUCRISA · Esbriet · FASENRA · Inspire Upper Airway Stimulation System · LONHALA MAGNAIR · NIOX VERO · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · PREVNAR - 13 · Pacemakers · Prolastin-C · Prolastin-C Liquid · SEEBRI · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TRELEGY ELLIPTA · TUDORZA PRESSAIR · The Monarch Airway Clearance System · UPTRAVI · UTIBRON · Utibron · Vascepa · Veltassa · Wakix · XYWAV · Xolair · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for pulmonary disease in FL.

Equivalent to $360,139 per 100 Medicare services performed
Looking for a pulmonary disease in Kissimmee?
Compare pulmonary diseases in the Kissimmee area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
45
Per 100K population
11.1
County median income
$68,711
Nearest hospital
HCA FLORIDA OSCEOLA HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2022
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Bitar is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 4%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Bitar experienced with critical care, first 30-74 min?
Based on Medicare claims data, Dr. Bitar performed 36 critical care, first 30-74 min services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bitar receive payments from pharmaceutical companies?
Yes. Dr. Bitar received a total of $129,650 from 32 companies across 470 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bitar's costs compare to other pulmonary diseases in Kissimmee?
Dr. Bitar's average Medicare payment per service is $174. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bitar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →